Washington, D.C. 20549
COSTAMARE INC.
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
INCORPORATION BY REFERENCE
The information contained in this Report on Form 6-K shall be incorporated by reference into our registration statements on Form F-3, as filed with the U.S. Securities and Exchange Commission on
July 6, 2016 (File No. 333-212415) and March 29, 2024 (File No. 333-278366) to the extent not superseded by information subsequently filed or furnished (to the extent we expressly state that we incorporate such furnished information by reference)
by us under the Securities Act of 1933 or the Securities Exchange Act of 1934, in each case as amended.
EXHIBIT INDEX
Monaco, October 15, 2025 – Costamare Inc. (“Costamare” or the “Company”) (NYSE: CMRE) announced today that it has entered into a Stock Subscription Agreement (the “Purchase
Agreement”) with Konstantinos Konstantakopoulos, pursuant to which Mr. Konstantakopoulos will purchase 1,200 shares of a new series of high-vote, non-economic preferred stock (the “Series F Preferred Stock”), for an aggregate purchase price of
$1,200.
Each share of Series F Preferred Stock shall entitle Mr. Konstantakopoulos to 50,000 votes on all matters submitted to a vote of the shareholders of the Company. The Series F Preferred Stock were established in
connection with the announcement on October 10, 2025, by the Ministry of Transport in China relating to the collection of special port fees from U.S.-linked vessels. While the Company does not believe that its vessels are subject to the
collection of special port fees, the issuance of the Series F Preferred Stock ensures that it is not possible for U.S. persons to control over 25% of the voting power of the Company because, following the completion of the purchase by Mr.
Konstantakopoulos, members of the Konstantakopoulos family (none of whom are U.S. persons) will control approximately 75.7% of the Company’s issued and outstanding voting rights. Prior to the issuance of the shares of Series F Preferred Stock
pursuant to the Purchase Agreement, the Konstantakopoulos family controlled approximately 63.6% of the Company’s issued and outstanding voting rights.
The Series F Preferred Stock shall not have any dividend or distribution rights, and shall not be entitled to any distributions upon any liquidation, dissolution or winding up of the Company other than its par
value. All shares of the Series F Preferred Stock are subject to redemption by the Company at any time in the sole discretion of the independent members of the Board of Directors of the Company (or a committee comprised thereof) and without the
consent of the holders of Series F Preferred Stock, for a redemption price equal to $1 per share. Effective on the date that is the fifth anniversary of the date of issuance of the shares of Series F Preferred Stock, all rights and powers of any
such shares that remain outstanding will automatically terminate and be of no further force or effect.
The Audit Committee of the Company, comprised solely of independent and disinterested directors, reviewed the Purchase Agreement and the Statement of Designation establishing the Series F Preferred Stock and
unanimously recommended that the Board of Directors of the Company approve the designation and issuance of the Series F Preferred Stock and the execution of the Purchase Agreement.
The terms of the Series F Preferred Stock are set forth in a Statement of Designation of Rights, Preferences and Privileges of Series F Preferred Stock of the Company, dated as of October 15, 2025 (the “Statement
of Designation”), a copy of which is attached hereto as Exhibit 99.1.
Forward-Looking Statements
This report contains “forward-looking statements”. In some cases, you can identify these statements by forward-looking words such as “believe”, “intend”, “anticipate”, “estimate”, “project”, “forecast”, “plan”, “potential”, “may”, “should”,
“could” and “expect” and similar expressions. These statements are not historical facts but instead represent only the Company’s belief regarding future results, many of which, by their nature, are inherently uncertain and outside of the
Company’s control. It is possible that actual results may differ, possibly materially, from those anticipated in these forward-looking statements. For a discussion of some of the risks and important factors that could affect future results, see
the discussion in the Company’s Annual Report on Form 20-F (File No. 001-34934) under the caption “Risk Factors”.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.